Posts

From $25,000 to $2,000: The New Era of Intraday Margin

From $25,000 to $2,000: The New Era of Intraday Margin Yesterday, April 14, 2026, marked the end of an era for retail trading. The SEC has officially granted accelerated approval to FINRA’s proposal to scrap the Pattern Day Trader (PDT) rule. For over 20 years, the $25,000 minimum has been a massive barrier, but the regulatory landscape has finally shifted to favor the individual trader. What’s Actually Changing? The "4 trades in 5 days" limit is being completely retired. Instead of counting how many times you trade, regulators are moving to a Risk-Based Intraday Margin Standard . The New Standards: The $2,000 Minimum: You no longer need $25k to trade unlimited intraday. You simply need a standard margin account, which carries a federal minimum of $2,000 . Real-Time Exposure: Your broker will now monitor your risk in real-time. As long as your account equity covers your active mar...
Post a Comment
Read more

OPAD — Showing Signs Of Life

OPAD Stock Watch: Is Offerpad Setting Up for a Breakout? Published: April 2026 Offerpad Solutions (NYSE: OPAD) is starting to show signs of life again. The stock has moved roughly 8–10% intraday , recently trading in the $0.77–$0.87 range with a noticeable uptick in volume. After a prolonged downtrend, traders are beginning to ask a familiar question: Is OPAD finally ready to break out? 📊 Quick Snapshot Market Cap: ~$40M (micro-cap) 52-Week High: ~$6.35 52-Week Low: ~$0.57 Current Range: ~$0.77–$0.87 Status: NYSE minimum bid compliance risk 🏠 What OPAD Actually Does Offerpad operates in the real estate technology (PropTech) space, best known for its iBuyer model —making cash offers on homes and streamlining transactions. The company has been shifting its focus toward: Fee-based brokerage services Renovation and home improvement revenue stream...
Post a Comment
Read more

COMP — Going Up?

COMP Stock (Compass, Inc.) - Trading Notes April 2026 COMP Stock (Compass, Inc.) Trading Notes Status: Bullish Signal Detected | Current Price: ~$7.21 (April 14, 2026) Market Snapshot Metric Current Value Market Cap ~$5.3B 52-Week Range $5.66 – $13.96 Beta (Volatility) ~2.0–2.6 (High Risk/High Reward) Valuation (P/S) ~0.8x (Undervalued vs. Peers) Current Trend YTD -30%+ (Deep Value Opportunity) Strategy & Scenarios Based on zero-lag momentum indicators and analyst pivots. Entry calculations based on ~$7.20 level. Scenario Suggested Entry ...
Post a Comment
Read more

High Conviction

The SNXX Blueprint: Hunting the Next Leveraged Breakout Today’s move in SNXX (Tradr 2X Long SNDK Daily ETF) was a textbook example of what high-conviction momentum looks like when everything aligns. With the underlying semiconductor/storage name pushing into a double-digit breakout , the 2X leveraged vehicle delivered amplified returns — fueled by surging relative volume and aggressive trader positioning. “This setup is the High-Conviction Leveraged Breakout — where a leading tech name clears key resistance and traders rotate into 2X vehicles to maximize exposure.” Why This Matters Moves like this don’t happen randomly. They typically emerge when: Sector leadership is clearly defined Institutional volume confirms the breakout Retail momentum piles into leveraged instruments The key is not chasing — it’s identifying the next setup before expansion . Immediate Peer Plays If you're tracki...
Post a Comment
Read more

CRDO Something Is Cooking

Credo Technology (CRDO): A Sharp Rebound in the AI Connectivity Space Credo Technology Group Holding Ltd (NASDAQ: CRDO ) delivered a strong performance on April 13, 2026, closing at approximately $134.29 after surging more than 12% in a single session. This move stands out against the broader market and semiconductor peers, reflecting renewed investor enthusiasm for the company’s role in powering high-speed connectivity for AI data centers. What Sparked Today’s Surge Two key developments converged to drive the momentum: Jefferies initiated coverage with a Buy rating and a $175 price target. Analysts highlighted a “significant disconnect” in how the market views Credo’s copper-based Active Electrical Cable (AEC) solutions. They argue that concerns over optical alternatives replacing copper are overstated — copper still offers compelling advantages in cost, power efficiency, and reach for many scale-out AI ...
Post a Comment
Read more

Detailed Opportunity Analysis

High-Probability Biotech Setups – April 2026 🚀 High-Probability Biotech Setups Week of April 13–17, 2026 Catalyst-driven trades built for momentum and asymmetric upside. Strategy: • Small sizing (1–2%) • Enter near support • Cut losers fast • Scale winners into strength 📊 Catalyst Overview TVTX – Travere Therapeutics PDUFA decision (FSGS kidney disease) 65–75% probability View Chart IDYA – Ideaya Biosciences Phase 2/3 melanoma data 50–65% View Chart MGTX – MeiraGTx Gene therapy durability data 70–85% View Chart ASMB – Assembly Biosciences HSV-2 clinical data (Gilead partner) 75–90% View Chart KURA – Kura Oncology Oncology combo data update 60–75% View Chart 🧬 Why These Matter TVTX: Rare kidney disease company. Approval = immediate revenue shift. IDYA: Precision oncology. Biomarker targeting increases success odds. MGTX: Gene therapy platform. Strong durability potential. ASMB: Backed by Gilead. Large unme...
Post a Comment
Read more

Weekend Report — Opportunities I See

High-Probability Explosive Biotech Plays - April 2026 🚀 High-Probability Explosive Gains Setups (Low Downside Focus) Next Week Catalysts: April 13–17, 2026 Data as of April 11, 2026 (Weekend) Built for scanner-style momentum trading (ASTS / ALLO / WULF-type runs) 📊 Quick Catalyst Overview Ticker Catalyst Date Event Est. Positive Probability TVTX April 13 PDUFA – FILSPARI sNDA (FSGS) 65–75% IDYA April 13 Phase 2/3 topline data (OptimUM-02) 50–65% MGTX April 16 3-year durability data + update 70–85% ASMB April 17 Phase 1b data (HSV-2, Gilead partnered) 75–90% KURA April 17 Updated combo oncology data + call 60–75% 📈 Trading Game Plan (Core Rules) Execution Framework: • Position size small: 1–2% max portfolio risk per trade • Entries: Near support / pre-catalyst consolidation zones • Stops: Hard stops below key support (no exceptions) • Profit taking: Scale out (50%) on first major move • Let runners ride w...
Post a Comment
Read more